Clinical Trial Update: A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly Patients [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing high-dose dual therapy to half-dose clarithromycin-containing bismuth quadruple therapy for Helicobacter pylori eradication i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Duodenal Ulcer Disease
• Helicobacter Pylori Infection

Drugs mentioned

• High-dose Dual Therapy
• clarithromycin-containing bismuth quadruple therapy

Snippet

Sponsor: Shandong University | Conditions: Helicobacter Pylori | Phase 4 | Status: UNKNOWN